Compare ISD & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISD | CLPT |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.1M | 467.9M |
| IPO Year | N/A | 2009 |
| Metric | ISD | CLPT |
|---|---|---|
| Price | $11.50 | $11.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 186.5K | ★ 648.6K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | ★ 9.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $32.54 |
| Revenue Next Year | N/A | $15.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $11.46 | $8.27 |
| 52 Week High | $14.79 | $30.10 |
| Indicator | ISD | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 28.58 | 34.82 |
| Support Level | $11.46 | $10.54 |
| Resistance Level | $12.09 | $11.86 |
| Average True Range (ATR) | 0.18 | 0.89 |
| MACD | -0.01 | -0.30 |
| Stochastic Oscillator | 7.92 | 11.90 |
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.